Eye Care Associates of Greater Cincinnati, Inc. – Trademark Portfolio

Entity Type: 03

Eye Care Associates of Greater Cincinnati, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. The owner is based in Cincinnati, OH.

Suite C

5535 Fair Lane

Cincinnati, OH 45227

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

APEXEYE
APEXEYE
Cancelled 2012
APEXEYE
APEXEYE
Cancelled 2012
APEX EYE
APEX EYE
Cancelled 2012
E
E
Cancelled 1998

Trademark Classifications

Eye Care Associates of Greater Cincinnati, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Eye Care Associates of Greater Cincinnati, Inc. have?

Eye Care Associates of Greater Cincinnati, Inc. has 4 U.S. trademarks filed with the USPTO.

What trademark classes does Eye Care Associates of Greater Cincinnati, Inc. file in?

Eye Care Associates of Greater Cincinnati, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What is Eye Care Associates of Greater Cincinnati, Inc.'s trademark registration success rate?

Eye Care Associates of Greater Cincinnati, Inc. has a 0% trademark registration rate, with 0 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.